ESC 365 - Soluble ST2 is strongly associated with outcomes in pulmonary arterial hypertension

HFA Premium Access

Soluble ST2 is strongly associated with outcomes in pulmonary arterial hypertension

Session: Pulmonary circulation

Topic: Pulmonary Hypertension

Speaker: Doctor K. Broch (Oslo, NO)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Doctor Kaspar Broch

Oslo University Hospital Rikshospitalet, Oslo (Norway)

1 presentation

0 follower

3 more presentations in this session

Long-term outcome of patients with transposition of the great arteries and a systemic right ventricle: a systematic review and meta-analysis

Speaker: Doctor M. Ansari Ramandi (Groningen, NL)

Right ventricular reverse remodeling after pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension

Speaker: Doctor H. Ravnestad (Oslo, NO)

Pulmonary hypertension due to left heart disease: first validation of the 2022 definitions in a prospective study, the PH-HF multicenter study

Speaker: Doctor C. Fauvel (Rouen, FR)

Access the full session

Pulmonary circulation

Speakers: Doctor K. Broch, Doctor M. Ansari Ramandi, Doctor H. Ravnestad, Doctor C. Fauvel

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources